Effect of Inhaled Insulin (AERx iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Insulin (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual initiation date changed from Dec 2006 to Nov 2006 as reported by ClinicalTrials.gov.
- 31 Jan 2008 Status change from in progress to discontinued, as reported by clinicaltrials.gov.